UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000006070
Receipt No. R000007183
Scientific Title A Phase II Study of Tri-weekly XELIRI with Bevacizumab for patient with unresectable or recurrent Colorectal Cancer as first -line chemotherapy.
Date of disclosure of the study information 2011/07/29
Last modified on 2017/04/30 18:28:28

No. Disposal Last modified on Item of update
1 Insert 2011/07/29 12:09:52
2 Update 2011/08/23 15:42:42 Institutions
3 Update 2012/01/31 17:16:46 Division name
Division name
Category of Funding Organization
Email1
Institutions
4 Update 2012/01/31 17:22:06 Recruitment status
5 Update 2013/01/29 13:39:40 Email
6 Update 2013/02/25 07:57:19 Recruitment status
7 Update 2013/08/14 15:41:37 UMIN ID1
8 Update 2014/01/29 09:10:55 TEL
Email
Last name of contact person
Last name of contact person
9 Update 2015/01/23 14:53:45 Key inclusion criteria
10 Update 2015/05/22 08:08:01 Email
Email
Email
Email1
11 Update 2016/02/24 19:10:44 Acronym
Acronym
12 Update 2016/08/01 08:12:42 Name of primary sponsor
Organization
13 Update 2016/08/01 08:14:25 Publication of results
Results
14 Update 2017/01/13 13:44:22 Public title
15 Update 2017/01/13 13:44:37 Anticipated trial start date
16 Update 2017/04/30 18:28:28 Recruitment status


Contact us.